PEGENZILEUKIN

UNII:	10WR240QN7
Formula:
Preferred Substance Name:	PEGENZILEUKIN
GSRS Full Record:	10WR240QN7 i

2573074-47-0
2-133-INTERLEUKIN 2 (125-SERINE) (HUMAN),(65-(N6-((2-(8-(4-((2-HYDROXYETHYL)AMINO)-1,4-DIOXOBUTYL)-8,9-DIHYDRO-1H(OR 3H)-DIBENZO(B,F)-1,2,3-TRIAZOLO(4,5-D)AZOCIN-1(OR 3)-YL)ETHOXY)CARBONYL)LYSINE)) ETHER WITH .ALPHA.-HYDRO-.OMEGA.-METHOXYPOLY(OXY-1,2-ETHANEDIYL)
HUMAN INTERLEUKIN 2 (IL2, T-CELL GROWTH FACTOR, TCGF) (2-133) VARIANT (A1 DELETED, PRO65>LYS, CYS125>SER), NON-GLYCOSYLATED, PRODUCED IN ESCHERICHIA COLI, CONJUGATED AT N6 OF K65 WITH A PEG DERIVATIVE (30KDA)
IL-2 VARIANT THOR-707
PEGENZILEUKIN [INN]
PEGENZILEUKIN [USAN]
PEGENZILEUKIN [WHO-DD]
PEGYLATED RECOMBINANT INTERLEUKIN-2 THOR-707
SAR444245
SAR-444245
THOR707
THOR-707

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

PEGENZILEUKIN

Synonyms and Mappings

Resources